862707960	862707960	CD	B-NP	O
|	|	NNP	I-NP	O
RHAMC	RHAMC	NNP	I-NP	O
|	|	VBD	B-VP	O
17702146	17702146	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3891451	3891451	CD	B-NP	O
|	|	CC	I-NP	O
8/27/2004	8/27/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/27/2004	8/27/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/20/2004	7/20/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ELVIS	ELVIS	NNP	B-NP	O
CULBERSON	CULBERSON	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

SERVICE	SERVICE	NN	B-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
Failure	Failure	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Referred	Refer	VBN	B-VP	O
by	by	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
despite	despite	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
progressive	progressive	JJ	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	I-NP	O
somnolence	somnolence	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
-LRB-	-LRB-	SYM	B-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
initial	initial	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
energy	energy	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
continuous	continuous	JJ	I-NP	O
decline	decline	NN	I-NP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
can	can	MD	B-VP	O
do	do	VB	I-VP	O
his	his	PRP$	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
living	living	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
gets	get	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
wheeling	wheel	VBG	I-VP	O
around	around	RB	B-ADVP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
wheelchair	wheelchair	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Emil	Emil	NNP	I-NP	O
Hattaway	Hattaway	NNP	I-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
and	and	CC	I-VP	O
noticed	notice	VBD	I-VP	O
a	a	DT	B-NP	O
desaturation	desaturation	NN	I-NP	O
to	to	TO	B-PP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
admitted	admit	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	I-NP	O
optimization	optimization	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ischemic	Ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
1.6	1.6	CD	B-NP	O
to	to	TO	I-NP	O
1.9	1.9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Gynecomastia	Gynecomastia	NNP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Venous	Venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Two-vessel	Two-vessel	JJ	B-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
showing	show	VBG	B-VP	O
EF	EF	NN	B-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
leg	leg	NN	I-NP	O
amputation	amputation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
diabetic	diabetic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Distant	Distant	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
FEM-POP	FEM-POP	NN	I-NP	O
surgeries	surgery	NNS	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
diaphragm	diaphragm	NN	I-NP	O
paralysis	paralysis	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
4/23/04	4/23/04	CD	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
,	,	,	O	O
trace	trace	VB	B-VP	O
aortic	aortic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
PASP	PASP	NN	B-NP	B-protein
of	of	IN	B-PP	O
36	36	CD	B-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	O
on	on	IN	B-PP	O
11/29/04	11/29/04	CD	B-NP	O
was	be	VBD	B-VP	O
5.6	5.6	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Linezolid	Linezolid	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
180	180	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-NP	I-protein
b.i.d.	b.i.d.	FW	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
on	on	IN	B-PP	O
4/13/04	4/13/04	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
11/9/04	11/9/04	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.7	96.7	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/66	140/66	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
repositioning	reposition	VBG	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
13	13	CD	B-NP	O
to	to	TO	B-PP	O
14	14	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
one-third	one-third	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
2/7	2/7	CD	B-NP	O
left	leave	VBD	B-VP	O
upper	upper	JJ	B-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
normoactive	normoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
clean	clean	JJ	I-ADJP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
fully	fully	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
crusting	crusting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
down	down	RP	B-PRT	O
,	,	,	O	O
very	very	RB	B-NP	O
swollen	swollen	JJ	I-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
with	with	IN	B-PP	O
skin	skin	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
and	and	CC	O	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LABORATORIES	LABORATORIES	NNS	B-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.7	5.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
101	101	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
71	71	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
125	125	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
473	473	CD	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
3.7	3.7	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
6.2	6.2	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.8	39.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
122	122	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
3.0	3.0	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
68.9	68.9	CD	I-NP	I-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
enlarged	enlarged	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
left	leave	VBD	B-VP	O
bundle-branch	bundle-branch	NN	B-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
peaked	peaked	JJ	I-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
I	I	NN	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
V5	V5	NN	B-NP	B-protein
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
represent	represent	VBP	B-VP	O
repolarization	repolarization	NN	B-NP	O
abnormality	abnormality	NN	I-NP	O
because	because	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
asymmetric	asymmetric	JJ	B-ADJP	O
,	,	,	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
LVH	LVH	NN	B-NP	B-protein
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
meet	meet	VB	I-VP	O
formal	formal	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
criteria	criterion	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Pump	Pump	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
130	130	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
well	well	RB	B-ADVP	O
putting	put	VBG	B-VP	O
out	out	RP	B-PRT	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
liters	liter	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
66/26	66/26	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
suggesting	suggest	VBG	B-VP	O
high	high	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
and	and	CC	I-NP	O
right-sided	right-sided	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
7.83	7.83	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
index	index	NN	I-NP	O
was	be	VBD	B-VP	O
3.09	3.09	CD	B-NP	O
,	,	,	O	O
SVR	SVR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
695	695	CD	B-NP	O
,	,	,	O	O
PVR	PVR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
174	174	CD	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	B-VP	O
still	still	RB	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
further	further	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
has	have	VBZ	B-VP	O
dropped	drop	VBN	I-VP	O
to	to	TO	B-PP	O
118	118	CD	B-NP	O
kg	kg	NN	I-NP	O
from	from	IN	B-PP	O
130	130	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
perspective	perspective	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NN	I-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
his	his	PRP$	B-NP	O
afterload	afterload	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
120	120	CD	I-NP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
except	except	IN	B-PP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
prepped	preppe	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
being	be	VBG	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
possible	possible	JJ	I-NP	O
causes	cause	NNS	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
including	include	VBG	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
underlying	underlie	VBG	I-NP	O
COPD	COPD	NN	I-NP	O
and	and	CC	I-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
on	on	IN	B-PP	O
10/11/04	10/11/04	CD	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
of	of	IN	B-PP	O
7.28	7.28	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	B-protein
of	of	IN	B-PP	O
76	76	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
of	of	IN	B-PP	O
67	67	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
37	37	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
giving	give	VBG	B-VP	O
an	an	DT	B-NP	O
A-a	A-a	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
ABG	ABG	NNP	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
7.43	7.43	CD	I-NP	O
,	,	,	O	O
carbon	carbon	NN	B-NP	O
dioxide	dioxide	NN	I-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
of	of	IN	B-PP	O
37	37	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hypoventilating	hypoventilate	VBG	I-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
overnight	overnight	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
sense	sense	NN	I-NP	O
of	of	IN	B-PP	O
comfort	comfort	NN	B-NP	O
of	of	IN	B-PP	O
breathing	breathing	NN	B-NP	O
improved	improve	VBD	B-VP	O
following	follow	VBG	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
BiPAP	BiPAP	NN	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
-	-	HYPH	I-NP	O
to	to	TO	B-PP	O
moderate-sized	moderate-sized	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
and	and	CC	O	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
improving	improve	VBG	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
tap	tap	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
attempted	attempt	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dermatological	Dermatological	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
skin	skin	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
lymphedema	lymphedema	NN	I-NP	O
.	.	.	O	O

Dermatology	Dermatology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
proper	proper	JJ	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
concerned	concern	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
superimposed	superimpose	VBN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
significant	significant	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Dermatology	Dermatology	NNP	B-NP	O
made	make	VBD	B-VP	O
specific	specific	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
for	for	IN	B-PP	O
care	care	NN	B-NP	O
specifically	specifically	RB	B-ADVP	O
,	,	,	O	O
one-quarter	one-quarter	JJ	B-NP	O
strength	strength	NN	I-NP	O
Dakin	Dakin	NNP	B-NP	O
's	's	POS	B-NP	O
soaks	soak	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADJP	O
moist-to-dry	moist-to-dry	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
legs	leg	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
betamethasone	betamethasone	NN	B-NP	O
cream	cream	NN	I-NP	O
and	and	CC	O	O
Lac-Hydrin	Lac-Hydrin	NN	B-NP	O
cream	cream	NN	I-NP	O
mixture	mixture	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
an	an	DT	B-NP	O
indurated	indurate	VBN	I-NP	O
plaque	plaque	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
bridge	bridge	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
nose	nose	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
Dermatology	Dermatology	NNP	B-NP	O
performed	perform	VBD	B-VP	O
a	a	DT	B-NP	O
shave	shave	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
showed	show	VBD	B-VP	O
endophytic	endophytic	JJ	B-NP	O
squamous	squamous	JJ	I-NP	O
proliferation	proliferation	NN	I-NP	O
with	with	IN	B-PP	O
atypia	atypia	NN	B-NP	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
layer	layer	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
fully	fully	RB	I-VP	O
represented	represent	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
potentially	potentially	RB	B-ADVP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
superficially	superficially	RB	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
and	and	CC	O	O
deeper	deep	JJR	B-NP	O
sampling	sampling	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
definitive	definitive	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O

Deeper	Deeper	NN	B-NP	O
sampling	sampling	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
occurred	occur	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Urology	Urology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
blood-tinged	blood-tinged	JJ	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
into	into	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Foley	Foley	NNP	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
dark	dark	JJ	B-NP	O
red	red	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
lightened	lighten	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
some	some	DT	B-NP	O
clots	clot	NNS	I-NP	O
evident	evident	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
urinate	urinate	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
tinged	tinge	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
lightened	lighten	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
followup	followup	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
with	with	IN	B-PP	O
Urology	Urology	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetes	diabete	NNS	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
glipizide	glipizide	NN	B-NP	O
and	and	CC	I-NP	O
lispro	lispro	NN	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
avoided	avoid	VBD	B-VP	O
contrast	contrast	NN	B-NP	O
dye	dye	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
increased	increase	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
process	process	NN	I-NP	O
going	go	VBG	B-VP	O
from	from	IN	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
1/23/04	1/23/04	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	I-NP	O
instructions	instruction	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-2068440	1-2068440	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Dong	Dong	NNP	B-NP	O
Munsterman	Munsterman	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Cragoson	Cragoson	NNP	I-NP	O
Balt	Balt	NNP	I-NP	O
Cleveandtope	Cleveandtope	NNP	I-NP	O
Lakefallspines	Lakefallspines	NNP	I-NP	O
Atlporti	Atlporti	NNP	I-NP	O
A	A	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Hilton	Hilton	NNP	B-NP	O
Duffie	Duffie	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Rell	Rell	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Ettegilb	Ettegilb	NNP	I-NP	O
Heightsnash	Heightsnash	NNP	I-NP	O
Chunah	Chunah	NNP	I-NP	O
Clellmorn	Clellmorn	NNP	I-NP	O
Hwy	Hwy	NNP	I-NP	O
.	.	.	O	O

,	,	,	O	O
Talake	Talake	NNP	B-NP	O
,	,	,	O	O
Massachusetts	Massachusetts	NNP	B-NP	O
13195	13195	CD	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ARNST	ARNST	NN	B-NP	O
,	,	,	O	O
GREGG	GREGG	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CIDRE	CIDRE	NN	B-NP	B-DNA
,	,	,	O	O
QUINCY	QUINCY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6983561	6983561	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/27/04	10/27/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/27/04	10/27/04	CD	B-NP	O

